跳转至内容
Merck
CN
  • Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.

Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.

Oncotarget (2014-10-23)
Claudia A Benavente, David Finkelstein, Dianna A Johnson, Jean-Christophe Marine, Ruth Ashery-Padan, Michael A Dyer
摘要

The retinoblastoma (Rb) family of proteins are key regulators of cell cycle exit during development and their deregulation is associated with cancer. Rb is critical for normal retinal development and germline mutations lead to retinoblastoma making retinae an attractive system to study Rb family signaling. Rb coordinates proliferation and differentiation through the E2f family of transcription factors, a critical interaction for the role of Rb in retinal development and tumorigenesis. However, whether the roles of the different E2fs are interchangeable in controlling development and tumorigenesis in the retina or if they have selective functions remains unknown. In this study, we found that E2f family members play distinct roles in the development and tumorigenesis. In Rb;p107-deficient retinae, E2f1 and E2f3 inactivation rescued tumor formation but only E2f1 rescued the retinal development phenotype. This allowed the identification of key target genes for Rb/E2f family signaling contributing to tumorigenesis and those contributing to developmental defects. We found that Sox4 and Sox11 genes contribute to the developmental phenotype and Hells and Uhrf1 contribute to tumorigenesis. Using orthotopic human xenografts, we validated that upregulation of HELLS and UHRF1 is essential for the tumor phenotype. Also, these epigenetic regulators are important for the regulation of SYK.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Trizma ® 碱, Primary Standard and Buffer, ≥99.9% (titration), crystalline
Sigma-Aldrich
Trizma ® 碱, BioPerformance Certified, meets EP, USP testing specifications, suitable for cell culture, ≥99.9% (titration)
Roche
cOmplete Mini蛋白酶抑制剂Cocktail, Tablets provided in a glass vial
Sigma-Aldrich
氯化钠, Molecular Biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
氯化钠 溶液, 5 M in H2O, BioReagent, Molecular Biology, suitable for cell culture
Sigma-Aldrich
氯化钠, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
氯化钠, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
氯化钠 溶液, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
三(羟甲基)氨基甲烷, ACS reagent, ≥99.8%
Sigma-Aldrich
缓血酸胺, meets USP testing specifications
Sigma-Aldrich
乙二胺四乙酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
Sigma 7-9®®, ≥99% (titration), powder or crystals
Sigma-Aldrich
Trizma ® 碱, BioUltra, Molecular Biology, ≥99.8% (T)
Sigma-Aldrich
乙二胺四乙酸, anhydrous, crystalline, BioReagent, suitable for cell culture
Sigma-Aldrich
氯化钠 溶液, 5 M
Sigma-Aldrich
抗 β-肌动蛋白抗体,小鼠单克隆, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
乙二胺四乙酸 溶液, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
乙二胺四乙酸 二钠盐 溶液, BioUltra, pH 8.0, ~0.5 M in H2O
Sigma-Aldrich
乙二胺四乙酸, 99.995% trace metals basis
Sigma-Aldrich
乙二胺四乙酸, BioUltra, anhydrous, ≥99% (titration)
Sigma-Aldrich
氯化钠, BioUltra, Molecular Biology, ≥99.5% (AT)
Sigma-Aldrich
Trizma ® 碱, ≥99.0% (T)
Sigma-Aldrich
氯化钠, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
氯化钠 溶液, BioUltra, Molecular Biology, ~5 M in H2O
Sigma-Aldrich
氯化钠, 99.999% trace metals basis
Supelco
氯化钠, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Trizma ® 碱, BioXtra, pH 10.5-12.0 (1 M in H2O), ≥99.9% (titration)
Sigma-Aldrich
Trizma ® 碱, ≥99.9% (titration), crystalline
Supelco
氯化钠, reference material for titrimetry, certified by BAM, >99.5%
Sigma-Aldrich
Trizma ® 碱, anhydrous, free-flowing, Redi-Dri, ≥99.9%